通过皮肤,输液和手术治疗以及对帕金森病睡眠功能障碍的影响
Karolina Popławska-Domaszewicz1, Raslan Ahmed2, Riaan van Coller3
1Department of Neurology, Poznan University of Medical Sciences, Poznan, Poland; Parkinson Foundation Centre of Excellence, King's College Hospital and King's College, London, UK; Honorary Faculty, Parkinson Foundation Centre of Excellence, King's College Hospital London, United Kingdom.
Sleep medicine clinics
|September 5, 2025
概括
帕金森病患者经常在口服多巴胺治疗时遇到睡眠问题. 非口服治疗,如脑下核深度刺激 (DBS),可以改善夜间症状和睡眠质量.
科学领域:
- 神经学
- 睡眠医学
- 运动障碍
背景情况:
- 在使用口服多巴胺替代疗法的帕金森病患者中,睡眠功能障碍很普遍.
- 目前的口服疗法在夜间覆盖率低于最佳,通常不会在夜间使用.
- 这导致严重的睡眠障碍和PD患者的生活质量下降.
研究的目的:
- 评估非口服治疗策略来治疗帕金森病的睡眠功能障碍.
- 将脑下核深度刺激 (DBS) 与其他非口服疗法在治疗夜间症状方面的有效性进行比较.
- 评估STN-DBS对PD患者客观和主观睡眠参数的影响.
主要方法:
- 对帕金森病的非口服疗法,包括透皮贴片和输液系统的现有文献和临床数据的审查.
- 对PD患者的脑下核深度刺激 (DBS) 的研究分析.
- 使用经过验证的睡眠量表,如帕金森病睡眠量表 (PDSS) 评估睡眠质量.
主要成果:
- 非口服疗法,包括透皮疗法和输液系统,有效地提供夜间多巴胺作用的支持.
- 脑下核的深度刺激 (DBS) 显示了帕金森病睡眠量表 (PDSS) 的显著改善.
- 在帕金森病患者中,STN- DBS可显著改善整体睡眠质量.
结论:
- 非口服疗法为帕金森病的夜间症状管理提供了可行的解决方案,解决了口服药物的局限性.
- 脑下核 (STN) 的深度脑刺激 (DBS) 是改善PD睡眠障碍的有希望的治疗选择.
- 需要进行进一步的比较研究,以充分阐明DBS与输液治疗在帕金森病的非运动和睡眠症状方面的益处.
相关概念视频
01:24Parkinson's Disease: Treatment
375
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
375
01:15Parkinson's Disease: Overview
702
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
702
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
236
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
236
01:19Management of Insomnia
319
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
319
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
123
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
123
01:15REM Sleep Behavior Disorder
378
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
378